“…Four families of bioactive lipids are involved in inflammation and immune regulation: eicosanoids, specialised pro-resolving mediators, lysoglycerophospholipids/sphingolipids and endocannabinoids, which are generated from ω-3 or ω-6 polyunsaturated fatty acids (PUFAs). Eicosanoids are key elements in inflammation, and have been linked with diseases, such as viral infections, neurodegenerative disorders [2], rheumatoid arthritis [3], atherosclerosis [4,5], acute coronary syndrome [6], cancer [7,8], systemic lupus erythematosus [9], multiple sclerosis [10], liver injury [11], celiac disease [12], diabetes [13], cystic fibrosis [14], renovascular disease [15], asthma [16] and muscle dysfunction [17]. In addition, fatty acids, the common components of complex lipids, often act as immunomodulatory factors [18,19].…”